Article

Answering four key questions about HTA market archetypes

How understanding the nuances can help biopharma companies succeed
Chelsey Campbell, Director, Global Consulting, explains why biopharma companies must understand the commonly established HTA market archetypes to better impact the commercialization process. Enter your information below to learn more.

Pardot Form

Related resources

Article

Insights from Pharma 2025: Ready or not? Preparing for the EU HTA wave

Webinar

How full pharmacovigilance outsourcing increases efficiency and accuracy

Article

Cencora ThinkLive Cell and Gene Therapy Virtual Summit 2025

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.